THY1 and breast neoplasm: The expression of CD90/Thy-1 is demonstrated in different cells at different locations in the body but also highly expressed in the aggressive high malignancy grade basal-like breast tumour cell line (Hs578T), pointing to this molecule as a promising breast tumour marker [26].